COMP does not directly modify the expression of genes involved in cartilage homeostasis in contrast to several other cartilage matrix proteins

References

• Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, Pols HA, Hazes JM, Koes BW. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Ann Rheum Dis 2005;64:682–7
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Welsch DJ, Pelletier JP. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001;15:805–29
   PubMed Web of Science ®Google Scholar
• Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 2006;20:983–1002
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463–516
   PubMed Web of Science ®Google Scholar
• Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003;5:94–103
   PubMed Web of Science ®Google Scholar
• Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859–69
   PubMed Web of Science ®Google Scholar
• Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011;112:3507–14
   PubMed Web of Science ®Google Scholar
• Richardson DW, Dodge GR. Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes. Am J Vet Res 2000;61:624–30
   PubMed Web of Science ®Google Scholar
• Aoki Y, Ohtori S, Ino H, Douya H, Ozawa T, Saito T, Moriya H, Takahashi K. Disc inflammation potentially promotes axonal regeneration of dorsal root ganglion neurons innervating lumbar intervertebral disc in rats. Spine 2004;29:2621–6
   PubMed Web of Science ®Google Scholar
• Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184–7
   PubMed Web of Science ®Google Scholar
• Ryu JH, Yang S, Shin Y, Rhee J, Chun CH, Chun JS. Interleukin-6 plays an essential role in hypoxia-inducible factor 2α-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum 2011;63:2732–43
   PubMed Web of Science ®Google Scholar
• Klatt AR, Paul-Klausch B, Klinger G, Kuhn G, Renno JH, Banerjee M, Malchau G, Wielckens K. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res 2009;27:65–70
   PubMed Web of Science ®Google Scholar
• Klatt AR, Zech D, Kuhn G, Paul-Klausch B, Klinger G, Renno JH, Schmidt J, Malchau G, Wielckens K. Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes. J Pathol 2009;218:241–7
   PubMed Web of Science ®Google Scholar
• Homandberg GA, Meyers R, Xie DL. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992;267:3597–604
   PubMed Web of Science ®Google Scholar
• Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A. Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J 1997;321(Pt 3):751–7
   PubMed Web of Science ®Google Scholar
• Klatt AR, Klinger G, Paul-Klausch B, Kuhn G, Renno JH, Wagener R, Paulsson M, Schmidt J, Malchau G, Wielckens K. Matrilin-3 activates the expression of osteoarthritis-associated genes in primary human chondrocytes. FEBS Lett 2009;583:3611–17
   PubMed Web of Science ®Google Scholar
• Klatt AR, Paul-Klausch B, Klinger G, Hillebrand U, Kuhn G, Kobbe B, Renno JH, Johannis W, Paulsson M, Wagener R. The matrilin-3 VWA1 domain modulates interleukin-6 release from primary human chondrocytes. Osteoarthritis Cartilage 2013;21:869–73
   PubMed Web of Science ®Google Scholar
• Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, Lawler J. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 1994;24:435–9
   PubMed Web of Science ®Google Scholar
• Efimov VP, Engel J, Malashkevich VN. Crystallization and preliminary crystallographic study of the pentamerizing domain from cartilage oligomeric matrix protein: a five-stranded α-helical bundle. Proteins 1996;24:259–62
   PubMed Web of Science ®Google Scholar
• Halasz K, Kassner A, Morgelin M, Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007;282:31166–73
   PubMed Web of Science ®Google Scholar
• Agarwal P, Zwolanek D, Keene DR, Schulz JN, Blumbach K, Heinegard D, Zaucke F, Paulsson M, Krieg T, Koch M, Eckes B. Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure. J Biol Chem 2012;287:22549–59
   PubMed Web of Science ®Google Scholar
• Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R. Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 2004;279:25294–8
   PubMed Web of Science ®Google Scholar
• Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, Lawler J. Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem 2007;282:24591–8
   PubMed Web of Science ®Google Scholar
• Di Cesare PE, Chen FS, Moergelin M, Carlson CS, Leslie MP, Perris R, Fang C. Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. Matrix Biol 2002;21:461–70
   PubMed Web of Science ®Google Scholar
• Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995;10:330–6
   PubMed Web of Science ®Google Scholar
• Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, Francomano CA, Prange CK, Lennon GG, Deere M, et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 1995;10:325–9
   PubMed Web of Science ®Google Scholar
• Saxne T, Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583–91
   PubMedGoogle Scholar
• Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151–60
   PubMedGoogle Scholar
• Hummel KM, Neidhart M, Vilim V, Hauser N, Aicher WK, Gay RE, Gay S, Häuselmann HJ. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. Br J Rheumatol 1998;37:721–8
   PubMedGoogle Scholar
• Di Cesare PE, Carlson CS, Stolerman ES, Hauser N, Tulli H, Paulsson M. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 1996;14:946–55
   PubMed Web of Science ®Google Scholar
• Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707–13
   PubMed Web of Science ®Google Scholar
• Verma P, Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker. J Orthop Res 2013;31:999–1006
   PubMed Web of Science ®Google Scholar
• Ganu V, Goldberg R, Peppard J, Rediske J, Melton R, Hu SI, Wang W, Duvander C, Heinegård D. Inhibition of interleukin-1α-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis Rheum 1998;41:2143–51
   PubMed Web of Science ®Google Scholar
• Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendas AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knäuper V. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett 2000;478:52–6
   PubMed Web of Science ®Google Scholar
• Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegard D, Hollander AP. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Matrix Biol 2003;22:267–78
   PubMed Web of Science ®Google Scholar
• Liu CJ, Kong W, Ilalov K, Yu S, Xu K, Prazak L, Fajardo M, Sehgal B, Di Cesare PE. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J 2006;20:988–90
   PubMed Web of Science ®Google Scholar
• Liu CJ, Kong W, Xu K, Luan Y, Ilalov K, Sehgal B, Yu S, Howell RD, Di Cesare PE. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem 2006;281:15800–8
   PubMed Web of Science ®Google Scholar
• Guo F, Lai Y, Tian Q, Lin EA, Kong L, Liu C. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum 2010;62:2023–36
   PubMed Web of Science ®Google Scholar
• Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom AM. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010;62:3574–83
   PubMed Web of Science ®Google Scholar
• Tan K, Duquette M, Joachimiak A, Lawler J. The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J 2009;23:2490–501
   PubMed Web of Science ®Google Scholar
• Wang L, Zheng J, Du Y, Huang Y, Li J, Liu B, Liu CJ, Zhu Y, Gao Y, Xu Q, Kong W, Wang X. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with α(7)β(1) integrin. Circ Res 2010;106:514–25
   PubMed Web of Science ®Google Scholar
• Chen FH, Thomas AO, Hecht JT, Goldring MB, Lawler J. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 2005;280:32655–61
   PubMed Web of Science ®Google Scholar
• Rock MJ, Holden P, Horton WA, Cohn DH. Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and αVβ3 integrin. Mol Cell Biochem 2010;338:215–24
   PubMed Web of Science ®Google Scholar
• Agarwal P, Schulz JN, Blumbach K, Andreasson K, Heinegard D, Paulsson M, Mauch C, Eming SA, Eckes B, Krieg T. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biol 2013;32:325–31
   PubMed Web of Science ®Google Scholar
• Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, Heinegard D, Paulsson M, Maurer P. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 2001;276:6083–92
   PubMed Web of Science ®Google Scholar
• Forslind K, Eberhardt K, Jonsson A, Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992;31:593–8
   PubMedGoogle Scholar
• Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990;144:499–505
   PubMed Web of Science ®Google Scholar
• Hoch JM, Mattacola CG, Medina McKeon JM, Howard JS, Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2011;19:1396–404
   PubMed Web of Science ®Google Scholar
• Sofat N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol 2009;90:463–79
   PubMed Web of Science ®Google Scholar
• Haudenschild DR, Hong E, Yik JH, Chromy B, Morgelin M, Snow KD, Acharya C, Takada Y, Di Cesare PE. Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein. J Biol Chem 2011;286:43250–8
   PubMed Web of Science ®Google Scholar
• Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006;11:529–43
   PubMed Web of Science ®Google Scholar
• Sun L, Wang X, Kaplan DL. A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials 2011;32:5581–9
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, Garnero P, Delaissé JM. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 2008;16:615–23
   PubMed Web of Science ®Google Scholar
• Zhang F, Yao Y, Su K, Pang PX, Zhou R, Wang Y, Wang DA. Redifferentiation of dedifferentiated chondrocytes by adenoviral vector-mediated TGF-β3 and collagen-1 silencing shRNA in 3D culture. Ann Biomed Eng 2011;39:3042–54
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 2003;162:833–42
   PubMed Web of Science ®Google Scholar
• van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB. TGF-β signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 2009;17:1539–45
   PubMed Web of Science ®Google Scholar
• Papathanasiou I, Malizos KN, Tsezou A. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res Ther 2012;14:R82
   PubMed Web of Science ®Google Scholar
• Hofer U, Syfrig J, Chiquet-Ehrismann R. Identification and characterization of a dimeric chicken fibronectin receptor. Subunit-specific monoclonal antibodies to the putative chicken α5 β1 integrin. J Biol Chem 1990;265:14561–5
   PubMed Web of Science ®Google Scholar
• Forsyth CB, Pulai J, Loeser RF. Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002;46:2368–76
   PubMed Web of Science ®Google Scholar
• Pulai JI, Del Carlo M Jr, Loeser RF. The α5β1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum 2002;46:1528–35
   PubMed Web of Science ®Google Scholar
• Homandberg GA, Costa V, Wen C. Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the α5 integrin receptor subunit. Osteoarthritis Cartilage 2002;10:938–49
   PubMed Web of Science ®Google Scholar
• Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, Loeser RF. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005;174:5781–8
   PubMed Web of Science ®Google Scholar
• Klatt AR, Nitsche DP, Kobbe B, Morgelin M, Paulsson M, Wagener R. Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development. J Biol Chem 2000;275:3999–4006
   PubMed Web of Science ®Google Scholar
• Mann HH, Sengle G, Gebauer JM, Eble JA, Paulsson M, Wagener R. Matrilins mediate weak cell attachment without promoting focal adhesion formation. Matrix Biol 2007;26:167–74
   PubMed Web of Science ®Google Scholar
• Klatt AR, Becker AK, Neacsu CD, Paulsson M, Wagener R. The matrilins: modulators of extracellular matrix assembly. Int J Biochem Cell Biol 2011; 43:320–30
   PubMed Web of Science ®Google Scholar
• Pullig O, Weseloh G, Klatt AR, Wagener R, Swoboda B. Matrilin-3 in human articular cartilage: increased expression in osteoarthritis. Osteoarthritis Cartilage 2002;10:253–63
   PubMed Web of Science ®Google Scholar
• Vincourt JB, Gillet P, Rat AC, Guillemin F, Netter P, Mainard D, Magdalou J. Measurement of matrilin-3 levels in human serum and synovial fluid using a competitive enzyme-linked immunosorbent assay. Osteoarthritis Cartilage 2012;20:783–6
   PubMed Web of Science ®Google Scholar
• Fresquet M, Jowitt TA, Ylostalo J, Coffey P, Meadows RS, Ala-Kokko L, Thornton DJ, Briggs MD. Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. J Biol Chem 2007;282:34634–43
   PubMed Web of Science ®Google Scholar
• Huang L, Jia J, Liu R. Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer’s disease and amnestic mild cognitive impairment. Neurosci Lett 2013;550:60–3
   PubMed Web of Science ®Google Scholar